Literature DB >> 15481348

Pathogenesis and screening for hepatocellular carcinoma.

Morris Sherman1.   

Abstract

Hepatocellular carcinoma is an increasingly common clinical problem. Investigators have begun to understand aspects of the pathogenesis of the tumor, mainly from a morphologic point of view. Preneoplastic lesions and early cancer may be difficult to distinguish radiologically. Nonetheless, programs for surveillance of liver cancer have been developed. Little uniformity exists in methods of surveillance, and even less in methods of investigation and follow-up after an abnormal result is obtained. This article attempts to bring some rigor to the understanding of hepatocellular carcinoma.

Entities:  

Mesh:

Year:  2004        PMID: 15481348     DOI: 10.1016/j.cld.2004.02.002

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  5 in total

Review 1.  Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

Authors:  Karen E Bremner; Ahmed M Bayoumi; Morris Sherman; Murray D Krahn
Journal:  Can J Gastroenterol       Date:  2007-08       Impact factor: 3.522

2.  Pathology for the HPB Surgeon.

Authors:  Chandralekha Tampi
Journal:  Indian J Surg       Date:  2011-12-13       Impact factor: 0.656

3.  Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation.

Authors:  Monica C Robotin; Melanie Q Kansil; Jacob George; Kirsten Howard; Steven Tipper; Miriam Levy; Nghi Phung; Andrew G Penman
Journal:  BMC Health Serv Res       Date:  2010-07-21       Impact factor: 2.655

4.  MRI texture analysis for differentiation of malignant and benign hepatocellular tumors in the non-cirrhotic liver.

Authors:  Daniel Stocker; Herman P Marquez; Matthias W Wagner; Dimitri A Raptis; Pierre-Alain Clavien; Andreas Boss; Michael A Fischer; Moritz C Wurnig
Journal:  Heliyon       Date:  2018-11-30

Review 5.  Hepatocellular carcinoma: early-stage management challenges.

Authors:  Derek J Erstad; Kenneth K Tanabe
Journal:  J Hepatocell Carcinoma       Date:  2017-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.